A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis | MicrobiomeTrials← Back to trialsNCT06968845
A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2026-02-02Est. Completion: 2027-09-30
Enrollment target: 120 participants Locations- UAB Lung Health Center, Birmingham, Alabama, United States
- University of Southern California, Los Angeles, California, United States
- Cedars Sinai Medical Center, Los Angeles, California, United States
- Paradigm Clinical Research Centers, LLC, San Diego, California, United States
- National Jewish Health, Denver, Colorado, United States
- Yale University School of Medicine, New Haven, Connecticut, United States
- Cleveland Clinic Florida, Weston, Florida, United States
- Indiana University, Indianapolis, Indiana, United States
- University of Kansas Medical Center, Kansas City, Kansas, United States
- Henry Ford Health, Detroit, Michigan, United States
- The Lung Research Center, LLC, Chesterfield, Missouri, United States
- Icahn School of Medicine at Mount Sinai, New York, New York, United States
- University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States
- University of Cincinnati Medical Center, Cincinnati, Ohio, United States
- Medical University of South Carolina, Charleston, South Carolina, United States
- El Paso Pulmonary Association, El Paso, Texas, United States
- Baylor College of Medicine, Houston, Texas, United States
- Baylor Scott and White Health, Temple, Texas, United States
- University of Utah, Salt Lake City, Utah, United States
- Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia
- Westmead Hospital, Westmead, New South Wales, Australia
- Launceston Respiratory and Sleep Centre, Launceston, Tasmania, Australia
- Box Hill Hospital, Box Hill, Victoria, Australia
- Thoraxklinik-Heidelberg gGmbH Studienzentrum ThoraxKliPS, Heidelberg, Baden-Wurttemberg, Germany
- Agaplesion Evangelisches Krankenhaus Mittelhessen, Giessen, Hesse, Germany
- Twoja Przychodnia NCM, Nowa Sól, Lubusz Voivodeship, Poland
- Instytut Gruzlicy i Chrob Pluc, Warsaw, Poland, Poland
- Salus Aegroti Praktyka Lekarska dr n. med. Grzegorz Gąsior, Sosnowiec, Silesian Voivodeship, Poland
- Medical University of Łódź, Lodz, Łódź Voivodeship, Poland
- Birmingham Chest Clinic, Birmingham, Birmingham, United Kingdom
- Queen Elizabeth Hospital Birmingham, Edgbaston, Birmingham, United Kingdom
- Royal Papworth Hospital, Trumpington, Cambridge, United Kingdom
- Royal Devon and Exeter Hospital, Exeter, Devon, United Kingdom
- Churchill Hospital, Oxford, Oxfordshire, United Kingdom
- Royal Infirmary of Edinburgh, Edinburgh, Scotland, United Kingdom
- Royal Brompton Hospital, London, United Kingdom
Other microbiome trials you might be interested in
Interstitial Lung DiseaseChronic Obstructive Pulmonary DiseaseHypoxemia
Fibrotic forms of interstitial lung disease (ILD) and chronic obstructive pulmonary disease (COPD) are chronic lung dise…
Buffalo, United StatesCompleted Oct 2027
Idiopathic Pulmonary Fibrosis
This is a randomized, placebo-controlled trial of metformin in 400 participants with idiopathic pulmonary fibrosis (IPF)…
Tucson, United StatesEst. completion Mar 15, 2029